Pediatric Sleep Apnea

What pediatric sleep apnea is

Obstructive sleep apnea (OSA) in children is the same fundamental phenomenon as in adults — repeated narrowing or closure of the upper airway during sleep, with associated drops in oxygen and brief micro-arousals — but the underlying mechanism, the visible behavior, and the treatment landscape all differ meaningfully.

The most common cause of pediatric OSA is enlargement of the tonsils and adenoids, the lymphoid tissue at the back of the throat and behind the nose. In young children these tissues are large relative to the size of the airway and reach peak size between roughly two and eight years of age. When they are large enough to crowd the airway, breathing during sleep — when the muscles supporting the airway naturally relax — becomes obstructed.

Other contributors exist. Obesity has become an increasingly important driver of pediatric OSA, particularly in older children and adolescents. Craniofacial differences (such as Down syndrome, Pierre Robin sequence, and some craniofacial syndromes) and certain neuromuscular conditions also increase risk. But for most otherwise-healthy young children, the airway problem is anatomic and treatable, and the path through it is well-defined.

How children present differently from adults

The most important fact about pediatric OSA — and the principal reason it is so often missed — is that children do not look sleepy when they are sleep-deprived. They look activated.

An adult with untreated OSA typically presents with daytime fatigue, irritability, difficulty concentrating, and falling asleep in low-stimulus situations. A child with the same physiology more commonly presents with:

• Hyperactivity, restlessness, and difficulty staying seated
• Impulsivity and difficulty waiting their turn
• Inattention, particularly during sustained classroom or homework tasks
• Mood disturbance, irritability, and difficulty regulating emotions
• Learning difficulties and academic underperformance relative to ability
• Growth deceleration in some severe cases, attributable in part to disrupted growth-hormone-rich deep sleep
• Bedwetting beyond the typical age, particularly when previously dry
• Morning headaches

The clinical resemblance to attention-deficit/hyperactivity disorder is striking. Studies estimating the prevalence of sleep-disordered breathing among children evaluated for ADHD have produced a wide range of figures, but a meaningful proportion of children carrying ADHD diagnoses turn out to have OSA, and treatment of the OSA frequently improves the behavioral picture substantially. This does not mean ADHD is "really" sleep apnea — many children have one and not the other, and some have both — but it does mean that any thoughtful workup for ADHD-pattern symptoms in a school-age child should include a question about snoring, witnessed pauses, restless sleep, and mouth breathing.

Symptoms parents should notice

Children almost never report sleep-disordered breathing themselves. Parents are the principal witnesses. The signs to attend to during sleep:

• Loud habitual snoring — most nights of the week, not just during a cold
• Witnessed pauses in breathing, often followed by a snort, gasp, or restless movement
• Mouth breathing during sleep, sometimes with the head extended back to keep the airway open
• Restless sleep — frequent position changes, unusual sleeping postures (sometimes propped up or sitting), kicked-off bedding
• Sweating during sleep beyond what room temperature would explain
• Difficulty waking in the morning despite an apparently adequate sleep duration

And during the day:

• Daytime mouth breathing, including during quiet activities like reading or watching screens
• Frequent ear infections or persistent nasal congestion
• Behavioral or attention problems at school, particularly when contrasted with the child's evident capability when interested or engaged
• Daytime sleepiness in older children and adolescents — though, as above, younger children often appear hyperactive instead

If several of these are present, the conversation to have is with the child's pediatrician — and to ask specifically about evaluation for obstructive sleep apnea. The phrasing matters; "my child snores" is sometimes met with reassurance, while "my child has loud habitual snoring with witnessed pauses and behavioral problems at school, and I'd like to understand whether obstructive sleep apnea is on the differential" reliably moves the conversation forward.

Risk factors

The strongest risk factors for pediatric OSA cluster into three categories: anatomic, body-composition, and developmental.

• Tonsillar and adenoidal hypertrophy — the dominant anatomic factor in young children; relative size matters more than absolute
• Obesity — particularly in school-age and adolescent children; the relationship is bidirectional, with OSA also contributing to weight gain through hormonal and behavioral pathways
• Craniofacial syndromes — including Down syndrome (in which OSA prevalence approaches 50%), Pierre Robin sequence, Treacher Collins syndrome, achondroplasia, and others affecting upper-airway anatomy
• Neuromuscular conditions — including muscular dystrophies and cerebral palsy, in which reduced muscle tone affects airway maintenance during sleep
• Family history of obstructive sleep apnea
• Allergies and chronic nasal congestion — increase upstream airway resistance and worsen obstruction
• Premature birth — associated with elevated OSA risk extending into childhood
• Race and ethnicity — some studies report higher prevalence among African American and Hispanic children, with the contributors likely a mix of genetic, environmental, and care-access factors

Children with high-risk syndromic conditions should be screened for OSA proactively as part of routine specialty care; for most other children, evaluation follows from parental observations and pediatrician suspicion.

How pediatric sleep apnea is diagnosed

Evaluation begins with the pediatrician's clinical assessment — history, physical examination of the tonsils and adenoidal area, and screening questions about sleep, behavior, and growth. If OSA is suspected, the standard objective test is an overnight in-lab polysomnography performed at a pediatric sleep center.

Why home sleep tests are not standard for children

Home sleep apnea tests are now routine for adults but are not validated as a substitute for in-lab polysomnography in most children. Children's sleep architecture, respiratory patterns, and arousal responses differ from adults' enough that the in-lab test — with full physiologic monitoring and trained pediatric sleep technologists — remains the standard. Centers experienced in pediatric sleep studies create child-friendly environments and parents typically stay overnight with younger children.

Pediatric AHI thresholds

The Apnea-Hypopnea Index (AHI) is interpreted differently in children than in adults. While an adult AHI under 5 events per hour is considered normal, in children the threshold for abnormal is much lower — most pediatric scoring criteria flag any obstructive AHI of 1 or more events per hour as abnormal. An AHI of 5 to 10 in a child is moderate; above 10 is severe. Symptoms and severity together drive the decision to treat.

Other useful pieces of the workup

An ear, nose, and throat (ENT) evaluation is frequently part of pediatric OSA workup, given that adenotonsillectomy is the first-line treatment in most cases. Lateral neck X-rays or nasal endoscopy can characterize adenoidal size when the tonsils alone do not appear large. For children with significant obesity, additional metabolic evaluation may be appropriate. Children with craniofacial or neuromuscular conditions are usually managed in coordination with their existing specialty teams.

Treatment options

Pediatric OSA treatment differs sharply from adult OSA treatment in its first-line move: in children, removing the obstructing tissue often resolves the condition; in adults, surgery is reserved for selected cases.

Adenotonsillectomy

Surgical removal of the tonsils and adenoids (T&A) is first-line treatment for pediatric OSA in most healthy non-obese children with adenotonsillar hypertrophy. Outcomes data — including the large CHAT trial of children with mild-to-moderate OSA — show substantial resolution of obstructive events in approximately 70–80% of healthy non-obese children, along with measurable improvements in behavior, attention, and quality of life. The procedure is one of the more common surgeries in childhood; risks are real (postoperative bleeding, dehydration, anesthesia-related events) but generally manageable in experienced pediatric centers. Children with severe OSA, significant obesity, craniofacial syndromes, or other comorbidities have lower resolution rates after T&A and frequently require additional treatment.

Weight management

For overweight or obese children with OSA — increasingly common in older children — weight reduction is a meaningful adjunct or, in some cases, the primary treatment. The relationship is bidirectional: untreated OSA disrupts the hormonal regulation of appetite and metabolism, making weight loss harder; treating OSA can make weight management more achievable. Pediatric weight-management programs work best with family involvement, are best matched to the child's developmental stage, and benefit from coordination with pediatric sleep specialists.

Continuous positive airway pressure (CPAP)

CPAP is used in children when adenotonsillectomy is not appropriate (severely obese children, children with craniofacial or neuromuscular conditions), when OSA persists after T&A, or while waiting for surgery. Adherence is the central challenge; pediatric sleep programs address this with mask-fitting tailored to children, behavioral training, family support, and developmentally appropriate strategies. CPAP works in children when adherence works.

Anti-inflammatory medications

For mild pediatric OSA — particularly when adenoidal enlargement is the principal contributor and tonsils are not severely enlarged — intranasal anti-inflammatory medications and oral leukotriene-modifying medications are sometimes used either as primary treatment or to bridge to surgery. The evidence base is most established in mild OSA; severe cases generally require surgical intervention.

Orthodontic interventions

Selected children — those with narrow palates contributing to airway crowding — may benefit from rapid maxillary expansion or other orthodontic procedures aimed at widening the upper airway. This is most often considered when conventional treatment has been insufficient or when craniofacial features point specifically to a maxillary contribution.

Treatment of allergies and nasal obstruction

Chronic nasal congestion increases upstream airway resistance and can worsen obstruction. Treating underlying allergies — through environmental measures and, when appropriate, medications — is a low-risk adjunct that frequently improves the overall picture.

What untreated pediatric sleep apnea costs

Untreated pediatric OSA is not a benign condition. The cumulative effect of repeated nighttime breathing interruptions — often hundreds per night — extends well beyond the immediate sleep problem.

• Neurocognitive impact — measurable deficits in attention, executive function, and academic performance, with documented improvement after effective treatment
• Behavioral and emotional impact — hyperactivity, irritability, mood disturbance, and oppositional behaviors, frequently misattributed to temperament, parenting, or attention-deficit disorder when the underlying driver is sleep-disordered breathing
• Cardiovascular impact — elevated blood pressure, increased heart-rate variability, and early markers of cardiovascular strain that are reversible with treatment
• Metabolic impact — disruption of hormones regulating appetite, insulin sensitivity, and growth, with downstream consequences for weight and metabolic health
• Growth impact — in severe cases, slowed growth attributable to disruption of slow-wave sleep, where most growth-hormone secretion occurs; effective treatment frequently produces catch-up growth
• Quality-of-life impact for the child and the family — chronic sleep disruption affects the entire household, and behavioral consequences ripple through school, family relationships, and the child's own self-concept

The bright side of an otherwise sobering list: pediatric OSA is, for most healthy non-obese children, a treatable condition with a clear and well-evidenced first-line intervention. Identification is the bottleneck. Once recognized, the path forward is well-defined.